POSTN and neoplasm: Yumm1.7- POSTN+ and Yumm1.7-CTR cell lines were subcutaneously inoculated in mice and, 1 week later (day 0), POSTN+ and CTR tumor-bearing mice were treated with MEKi for 5 days.